General Information
BounceWatch is an independent company data service, not affiliated with Phablecare. To contact Phablecare, visit phablecare.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Phablecare compare?
A PDF of Phablecare and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Phablecare soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
India Market
Health Care
About Phablecare
Business keywords: Technology, Chronic Diseases, Predictive Care, Personalized Care, Digital Therapeutics, Health Assistant, Patient Care, Doctor-Patient Communication, Health Monitoring, Treatment Adherence, Healthcare Ecosystem
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | INR1.87B | 8 | 11 Apr 2022 | |
| Non Equity Assistance | Undisclosed | 1 |
Google for Startups
|
11 Jan 2022 |
| Series A | INR140.00M | 1 | 09 Sep 2021 | |
| Series A | $12.00M | 4 | 07 Jan 2021 | |
| Seed Round | $1.00M | 6 | 05 May 2020 | |
| Seed Round | $220.00K | 3 | 01 Sep 2019 | |
| Seed Round | $150.00K | 1 | 25 Jul 2019 | |
| Seed Round | $300.00K | 1 | 04 Jul 2018 |
Phablecare Alternatives & Competitors
View All AlternativesDigital therapeutics and remote monitoring medtech to optimise treatment adherence, automation, and...
Creating continuous care in diabetes
Measuring and managing complex chronic illness using wearable technology
FAQ About Phablecare
Source: BounceWatch company record for Phablecare, https://bouncewatch.com/company/phablecare, updated 30 December 2024. When citing, please name BounceWatch and link this page.